Agreed. However AF is trying to put a cloud of doubt over the management here. He has nothing to say about Leronlimab as there is nothing negative to say, LOL. IMO, it is a strong product and should come out of the trails with Leronlimab in huge demand and on top of the market.
I studied your words. This is a clear concise statement that can not be argued. You are correct. While you did not say it, once we have Flu approval many Big Pharma Corps will loose Billions of revenues and we gain the revs.
For you on the wild side think about buying puts on big pharma in the weeks after our FDA approval.
Options expire and are dangerous and highly speculative. Be careful. Small change type funds.
Gilead sat on their thumbs, nose in the air, assessing CYDY as nothing more than a bothersome mosquito that they would squash at a whims notice. They miscalculated and they will now pay the price. Gilead was once a tiny biotech like CYDY - it’s not impossible to do what they did especially when you have the next Humira on steroids.
News 
Market Data 
Discover 
AI
